Praxis Precision Medicines saw the highest growth of 170% in patent filings in November and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 139% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Praxis Precision Medicines‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Praxis Precision Medicines has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with 16 publications in Q4 2023

The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings and grants with nearly 84% filings and 0% grants. The World Intellectual Property Organization(WIPO), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Praxis Precision Medicines is filings its patents. Among the top granted patent authorities, Praxis Precision Medicines has 100% of its grants in United States(US)

Johnson & Johnson and Pfizer could be the strongest competitors for Praxis Precision Medicines

Patents related to rare diseases lead Praxis Precision Medicines's portfolio

Praxis Precision Medicines has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.

Epilepsy related patents lead Praxis Precision Medicines portfolio followed by epileptic encephalopathy, and dravet syndrome (severe myoclonic epilepsy of infancy)

Praxis Precision Medicines has highest number of patents in epilepsy followed by epileptic encephalopathy, dravet syndrome (severe myoclonic epilepsy of infancy), infantile spasm (west syndrome), and seizures. For epilepsy, nearly 12% of patents were filed and 8% of patents were granted in Q4 2023.

For comprehensive analysis of Praxis Precision Medicines's filings and grants, buy the databook here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.